Clinical Trial Update: The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial exploring metformin as an adjunct to antidepressants in major depressive disorder has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Sadat City University | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED